Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib”

519 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 519 results

Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Testing effectiveness (Phase 2)UnknownNCT03144843
What this trial is testing

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Sun Yat-sen University 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04639180
What this trial is testing

Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 687
Testing effectiveness (Phase 2)UnknownNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Testing effectiveness (Phase 2)UnknownNCT05342389
What this trial is testing

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090
What this trial is testing

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Testing effectiveness (Phase 2)UnknownNCT04303741
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Not applicableUnknownNCT03531931
What this trial is testing

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

Who this might be right for
Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety
The First Affiliated Hospital of Xiamen University 20
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Large-scale testing (Phase 3)Looking for participantsNCT06485466
What this trial is testing

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaTransarterial ChemoembolizationCamrelizumab+1 more
Guohui Xu 101
Testing effectiveness (Phase 2)Looking for participantsNCT06475209
What this trial is testing

Adebrelimab + Apatinib in SCLC Maintenance Therapy

Who this might be right for
SCLC
Tang-Du Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02878057
What this trial is testing

Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)

Who this might be right for
Breast Cancer
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)UnknownNCT04014101
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 40
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Testing effectiveness (Phase 2)UnknownNCT04901754
What this trial is testing

Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Henan Cancer Hospital 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06081595
What this trial is testing

Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

Who this might be right for
Relapsed Ovarian Cancer
Jin Li 54
Large-scale testing (Phase 3)UnknownNCT02875457
What this trial is testing

Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 100
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451290
What this trial is testing

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Load More Results